Biotech · Private company
SpyGlass Pharma, Inc.
Track this companyFree. Adds SpyGlass Pharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Bimatoprost Implant SystemPhase 3 · CataractClinicalTrials.gov · fetched Nov 12, 2026
- Commercial IOLPhase 3 · CataractClinicalTrials.gov · fetched Nov 12, 2026
- SpyGlass IOLPhase 3 · CataractClinicalTrials.gov · fetched Nov 12, 2026
- Timolol Maleate Ophthalmic Solution, 0.5%Phase 3 · CataractClinicalTrials.gov · fetched Nov 12, 2026
- Bimatoprost Implant System (High Dose)Phase 2 · CataractClinicalTrials.gov · fetched Nov 12, 2026
- Bimatoprost Implant System (Low Dose)Phase 2 · CataractClinicalTrials.gov · fetched Nov 12, 2026
- Commercially Available Aspheric Monofocal Non-Yellow Chromophore IOLPhase 2 · CataractClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)PHASE3 · RECRUITING · started Oct 28, 2025ClinicalTrials.gov NCT07218796 · fetched Nov 12, 2026
- Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)PHASE3 · RECRUITING · started Oct 15, 2025ClinicalTrials.gov NCT07218783 · fetched Nov 12, 2026
- Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic SolutionPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Oct 13, 2023ClinicalTrials.gov NCT06120842 · fetched Nov 12, 2026